Compare HELE & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HELE | TECX |
|---|---|---|
| Founded | 1968 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 436.1M | 366.8M |
| IPO Year | N/A | 2018 |
| Metric | HELE | TECX |
|---|---|---|
| Price | $17.02 | $23.41 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $22.00 | ★ $80.40 |
| AVG Volume (30 Days) | ★ 788.3K | 502.8K |
| Earning Date | 01-08-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,802,156,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.67 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.29 | $13.70 |
| 52 Week High | $60.42 | $36.11 |
| Indicator | HELE | TECX |
|---|---|---|
| Relative Strength Index (RSI) | 38.72 | 57.70 |
| Support Level | $17.95 | $16.77 |
| Resistance Level | $19.44 | $25.00 |
| Average True Range (ATR) | 0.99 | 2.38 |
| MACD | 0.04 | 0.17 |
| Stochastic Oscillator | 21.27 | 71.78 |
Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home and Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty and Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.